Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,192 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC

NCT03564197

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • MeanderMC Amersfoort, Netherlands
  • VUmc Amsterdam, Netherlands
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
View Trial Details
Completed

Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

NCT03829332

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Alaska Clinical Research Center ( Site 0511) Anchorage, Alaska, United States
  • Ironwood Cancer & Research Centers ( Site 0541) Chandler, Arizona, United States
  • CBCC Global Research, Inc. ( Site 0532) Bakersfield, California, United States
  • Scripps Cancer Center ( Site 0521) La Jolla, California, United States
View all 162 locations
View Trial Details
Completed

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

NCT02523469

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cleveland Clinic Florida Weston, Florida, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Completed

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT04384146

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Completed

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

NCT05577702

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Guangzhou Medical Universitydatansha Hospital) Guangzhou, Guangdong, China
View all 14 locations
View Trial Details
Completed

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

NCT02917993

Conditions
Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • University of California San Diego, 3855 Health Sciences Drive, Mc 0987 La Jolla, California, United States
  • University California San Francisco Thoracic Surgery and Oncology Clinic, 1600 Divisadero Street, Floor 4 San Francisco, California, United States
  • Innovative Clinical Research Institute, 15111 Whittier Blvd., Suite 216 Whittier, California, United States
  • Rocky Mountain Cancer Center, 1800 Williams Street, Suite 200 Denver, Colorado, United States
View all 31 locations
View Trial Details

Related conditions